Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2013 by Nanfang Hospital of Southern Medical University.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Sun Yat-sen University
Peking University People's Hospital
Guangdong General Hospital
Guangzhou General Hospital of Guangzhou Military Command
Southern Medical University, China
Third Affiliated Hospital, Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou First Municipal People’s Hospital
Zhongshan People's Hospital, Guangdong, China
Information provided by (Responsible Party):
Nanfang Hospital of Southern Medical University
ClinicalTrials.gov Identifier:
NCT01765660
First received: January 5, 2013
Last updated: January 8, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)